SULLIVAN TABLES Flashcards Preview

MES > SULLIVAN TABLES > Flashcards

Flashcards in SULLIVAN TABLES Deck (227)
Loading flashcards...
1
Q

CHARACTERIZED BY DISCRETE ATTACKS OF NEUROLOGICAL DEFICITS WITH EITHER FULL OR PARTIAL RECOVERY IN SUBSEQUENT WEEKS TO MONTHS

A

RELAPSING REMITTING MS

2
Q

% OF RELAPSING REMITTING MS

A

85%

3
Q

CHARACTERIZED BY LACK OF DISEASE PROGRESSION

A

RELAPSING REMITTING MS

4
Q

MAY BE THE RESULT OF PROGRESSIVE AXONAL LOSS RATHER THAN NEW LESIONS

A

SECONDARY PROGRESSIVE MS

5
Q

CHARACTERIZED BY DISEASE PROGRESSION AND STEADY FUNCTIONAL DECLINE FROM ONSET, PT. MAY EXPERIENCE MODEST FLUCTUATIONS IN NEUROLOGICAL DISABILITY BUT DISCRETE ATTACK DO NOT OCCUR

A

PRIMARY PROGRESSIVE MS

6
Q

PRIMARY PROGRESSIVE MS %

A

10%

7
Q

CHARACTERIZED BY STEADY DETERIORATION IN DISEASE FROM ONSET BUT WITH OCCASIONAL ACUTE ATTACKS

A

PROGRESSIVE RELAPSING MS

8
Q

% OF PROGRESSIVE RELAPSING MS

A

5%

9
Q

STABLE PATIENT MAY HAVE LOCAL INFLAMMATORY ACTIVITY THAT IS CLINICALLY ABSENT

A

RELAPSING REMITTING

10
Q

ASSOCIATED WITH LATER ONSET (MEAN 40Y/O) AND MORE EQUAL GENDER DISTRIBUTION

A

PRIMARY PROGRESSIVE MS

11
Q

INTERVALS IN BETWEEN ATTACKS ARE CHARACTERIZED BY CONTINUING DISEASE PROGRESSION

A

PROGRESSIVE RELAPSING MS

12
Q

DEGENERATION OF CORTICOSPINAL TRACTS, NEURONS IN THE MOTOR CORTEX AND BRAINSTEM AND ANTERIOR HORN CELLS IN THE SC

A

ALS

13
Q

DEGENERATION OF UMN

A

PRIMARY LATERAL SCLEROSIS

14
Q

DEGENERATION OF MOTOR NEURONS OF CN 9-12

A

PROGRESSIVE BULBAR PALSY

15
Q

LOSS OR CHROMATOLYSIS OF MOTOR NEURONS OF THE SC AND BRAINSTEM

A

PROGRESSIVE MUSCULAR ATOPHY

16
Q

STAGE 1 HOEHN YAHR

A

MINIMAL/ABSENT ; UNILAT

17
Q

STAGE 2 HOEHN YAHR

A

MINIMAL/BILATERAL/MIDLINE INVOLVEMENT, BALANCE INTACT

18
Q

STAGE 3 HOEHN YAHR

A

IMPAIRED RIGHTING REFLEXES

19
Q

STAGE 4 HOEHN YAHR

A

ALL SX PRESENT AND SEVERE, STANDING AND WALKING ONLY POSSIBLE WITH ASSIST

20
Q

STAGE 5 HOEHN YAHR

A

CONFINED TO BED/W/C

21
Q

pt. reacts inconsistently and nonpurposefully to stimuli in a nonspecific manner

A

GENERALIZED RESPONSE RLA 2

22
Q

PT. APPEARS TO BE IN A DEEP SLEEP AND IS COMPLETELY UNRESPONSIVE TO STIMULI

A

RLA 1 NO RESPONSE

23
Q

PT. REACTS SPECIFICALLY BUT INCONSISTENTLY TO STIMULI, MAY FOLLOW SIMPLE COMMAND SUCH AS CLOSING EYES IN AN INCONSISTENT DELAYED MANNER

A

RLA 3 LOCALIZED RESPONSE

24
Q

HEIGHTENED STATE OF ACTIVITY, BIZARRE AND NON-PURPOSEFUL BEHAVIOR

A

RLA 4 CONFUSED AGIT

25
Q

CONFABULATION PRESENT, DOES NOT DISCRIMINATE BETWEEN OBJECTS AND PERSONS.

A

RLA 4 CONFUSED AGIT

26
Q

ABLE TO RESPOND TO SIMPLE COMMANDS FAIRLY CONSISTENTLY BUT RESPONSES ARE NON PURPOSEFUL OR FRAGMENTED WITH INC COMPLEXITY

A

RLA 5 CONFUSED INAPPROPRIATE

27
Q

GOAL DIRECTED BEHAVIOR BUT IS DEPENDENT ON EXTERNAL INPUT OR DIRECTION

A

RLA 6 CONFUSED APP

28
Q

GROSS ATTENTION TO ENVIRONMENT BUT IS HIGHLY DISTRACTIBLE AND LACKS ABILITY TO FOCUS ATTENTION ON A SPECIFIC TASK

A

RLA V

29
Q

FOLLOWS SIMPLE DIRECTIONS CONSISTENTLY AND SHOWS CARRYOVER FOR RELEARNED TASKS SUCH AS SELF CARE

A

RLA VI

30
Q

PAST MEMORIES SHOW MORE DEPTH AND DETAIL THAN RECENT MEMORY

A

RLA VI

31
Q

PT APPEARS APPROPRIATE AND ORIENTED WITHIN HOSPITAL/HOME; ROBOT LIKE

A

RLA VII

32
Q

SHOWS CARRYOVER FOR NEW LEARNING BUT AT A DECREASED RATE, JUDGMENT REMAINS IMPAIRED

A

RLA VII

33
Q

BLUISH GRAY DISCOLORATION OF THE SKIN AND MUCUS MEMBRANE

A

CYANOSIS

34
Q

REDDENED AREA OF SKIN D/T INCREASED BLOOD FLOW

A

ERYTHEMA

35
Q

DIFFUSED REDNESS OF FACE RELATED TO EMOTION, FEVER AND INC TEMPERATURE

A

FLUSHING

36
Q

TINY RED OR PURPLE HEMORRHAGIC SPOTS D/T CAPILLARY BLEEDING

A

PETECHIAE

37
Q

NO PERCEPTIBLE PULSE EVEN WITH MAX PRESSURE

A

ABSENT - 0

38
Q

BARELY PERCEPTIBLE , EASILY OBLITERATED WITH SLIGHT PRESSURE, FADES IN AND OUT

A

THREADY - 1+

39
Q

DIFFICULT TO PALPATE, OBLITERATED WITH SLIGHT PRESSURE

A

WEAK - 2+

40
Q

EASY TO PALPATE, REQUIRES MOD PRESSURE TO OBLITERATE

A

NORMAL 3+

41
Q

VERY STRONG HYPERACTIVE, IS NOT OBLITERATED WITH MOD PRESSURE

A

BOUNDING 4+

42
Q

ALTERNATES B/W PERIOD OF FEVER AND PERIOD OF NORMAL TEMPERATURE

A

INTERMITTENT

43
Q

FLUCTUATES MORE THAN 3.6 F OR 2 C within a 24 hr period but remains above normal

A

REMITTENT

44
Q

PERIODS OF FEVER ARE INTERSPERSED WITH NORMAL TEMP, EACH LAST AT LEAST ONE DAY AKA RECURRENT FEVER

A

RELAPSING

45
Q

BODY TEMP MAY FLUCTUATE SLIGHTLY BUT IS CONSTANTLY ABOVE NORMAL

A

CONSTANT

46
Q

MAS 0

A

NO INCREASE IN MM TONE

47
Q

MAS 1

A

SLIGHT INCREASE IN MM TONE , MANIFESTED BY A CATCH AND RELEASE OR BY MIN RESISTANCE AT THE END OF THE ROM

48
Q

MAS 1+

A

SLIGHT INCREASE IN MM TONE, WITH A CATCH, FOLLOWED BY MINIMAL RESISTANCE THROUGHOUT REMAINDER (< HALF OF ROM)

49
Q

MAS 2

A

MORE MARKED INCREASED IN MM TONE BUT AFFECTED PART STILL EASILY MOVED

50
Q

MAS 3

A

MARKED INCREASE IN MM TONE , PASSIVE MVT IS DIFFICULT

51
Q

MAS 4

A

AFFECTED PART RIGID IN FLEXION OR EXTENSION

52
Q

RAPID UPSTROKE AND DOWNSTROKE AND A SHORTENED PEAK

A

CORRIGAN’S / WATER HAMMER PULSE

53
Q

REGULAR PULSE RHYTHM WITH ALTERNATION OF WEAK AND STRONG BEATS

A

PULSUS ALTERNANS

54
Q

IRREGULAR PULSE RHYTHM IN WHICH PREMATURE BEATS ALTERNATE WITH SINUS BEATS

A

PULSUS BIGEMINUS

55
Q

A STRONG UPSTROKE, DOWNSTROKE AND A SECOND UPSTROKE DURING SYSTOLE

A

PULSUS BISFERIENS

56
Q

PULSE WITH A MARKEDLY DECREASED AMPLITUDE DURING INSPIRATION

A

PULSUS PARADOXUS

57
Q

PULSUS BISFERIENS INDICATES?

A

AORTIC INSUFFICIENCY, AORTIC REGURGITATION AND AORTIC STENOSIS

58
Q

CORRIGAN’S PULSE / WATER HAMMER PULSE

A

PATENT DUCTUS ARTERIOSUS

59
Q

PULSUS PARADOXUS MAY INDICATE?

A

PERICARDIAL TAMPONADE

60
Q

NORMAL RESPIRATIONS WITH EQUAL RATE AND DEPTH 12-20 CPM

A

EUPNEA

61
Q

REGULAR BUT ABNORMALLY DEEP AND INCREASE IN RATE

A

KUSSMAUL’S RESPIRATION

62
Q

IRREGULAR SHALLOW ALTERNATING WITH PERIODS OF APNEA

A

BIOT’S

63
Q

GRADUAL INCREASE IN DEPTH FOLLOWED BY GRADUAL DECREASE AND THEN A PERIOD OF APNEA

A

CHEYNE-STOKES BREATHING

64
Q

APNEA

A

THE ABSENCE OF BREATHING

65
Q

SENSATION EXPERIENCED AT A SITE REMOTE FROM POINT OF STIMULATION

A

ALLESTHESIA

66
Q

PAINFUL BURNING SENSATION ALONG THE DISTRIBUTION OF NN

A

CAUSALGIA

67
Q

PAIN PRODUCED BY A NON NOXIOUS STIMULUS

A

ALLODYNIA

68
Q

LOSS OF LIGHT TOUCH SENSIBILITY

A

THIGMANESTHESIA

69
Q

TOUCH SENSATION PERCEIVED AS PAIN

A

DYSESTHESIA

70
Q

ACCESSORY JT MOTION: ANKYLOSED JT

A

GRADE 0

71
Q

ACCESSORY JT MOTION: CONSIDERABLE HYPOMOBILITY

A

GRADE 1

72
Q

ACCESSORY JT MOTION: SLIGHT HYPOMOBILITY

A

GRADE 2

73
Q

WHAT ACC JT MOTION GRADE/S IS GRADE 1 AND 2 JT MOB INDICATED?

A

GRADE 1 AND 2

74
Q

ACCESSORY JT MOTION: NORMAL

A

GRADE 3

75
Q

ACCESSORY JT MOTION: SLIGHT HYPERMOBILITY

A

GRADE 4

76
Q

ACCESSORY JT MOTION: CONSIDERABLE HYPERMOBILITY

A

GRADE 5

77
Q

ACCESSORY JT MOTION: UNSTABLE

A

GRADE 6

78
Q

ACCESSORY JT MOTION: JT MOB IS NOT INDICATED AND SURGERY SHOULD BE CONSIDERED?

A

GRADE 0 AND GRADE 6

79
Q

ATLEAST 50% BUT NOT FULL ROM AGAINST GRAVITY

A

3 -

80
Q

LIGAMENTOUS INSTABILITY: GRADE 1

A

0-5 mm

81
Q

LIGAMENTOUS INSTABILITY: GRADE 2

A

6-10 mm

82
Q

LIGAMENTOUS INSTABILITY: GRADE 3

A

11-15 mm

83
Q

LIGAMENTOUS INSTABILITY: GRADE 4

A

> 15 mm

84
Q

PNS/SNS: hypervigilance

A

SNS

85
Q

PNS/SNS: PUPILS CONSTRICT

A

PNS

86
Q

PNS/SNS: HR DECREASES

A

PNS

87
Q

PNS/SNS: GLUCOSE PRODUCTION AND RELEASE INCREASES

A

SNS

88
Q

PNS/SNS: DIGESTION SLOWS

A

SNS

89
Q

PNS/SNS: DIGESTION RETURNS

A

PNS

90
Q

PNS/SNS: SWEATING INCREASES

A

SNS

91
Q

PNS/SNS: SWEATING CEASES

A

PNS

92
Q

PNS/SNS: BF TO MM INC , BF TO SKIN AND VISCERA DEC

A

SNS

93
Q

PNS/SNS: BF TO SKIN AND VISCERA INC

A

PNS

94
Q

PNS/SNS: ACTIVATION OF MASS MM

A

SNS

95
Q

PNS/SNS: RELAXATION OF MUSCLES

A

PNS

96
Q

PNS/SNS: BP INC

A

SNS

97
Q

PNS/SNS: BRONCHODILATION

A

SNS

98
Q

(+)/(-) FEATURE OF UMN: PARESIS

A

-

99
Q

(+)/(-) FEATURE OF UMN: CLONUS

A

+

100
Q

(+)/(-) FEATURE OF UMN: ASSOCIATED RXN

A

+

101
Q

(+)/(-) FEATURE OF UMN: FATIGUE

A

-

102
Q

(+)/(-) FEATURE OF UMN: BABINSKI

A

+

103
Q

(+)/(-) FEATURE OF UMN: EXAGGERATED DTRS

A

+

104
Q

(+)/(-) FEATURE OF UMN: SYNERGIES

A

+

105
Q

(+)/(-) FEATURE OF UMN: LOSS OF DEXTERITY

A

-

106
Q

(+)/(-) FEATURE OF UMN: DISTURBANCE IN MVT

A

+

107
Q

JAW REFLEX

A

CN V

108
Q

BICEPS REFLEX

A

C5-C6

109
Q

BRACHIORADS REFLEX

A

C5,C6

110
Q

TRICEPS REFLEX

A

C6,C7

111
Q

ACHILLES REFLEX

A

S1-S2

112
Q

LATERAL HAMS REFLEX

A

S1-S2

113
Q

MEDIAL HAMS REFLEX

A

L4-L5

114
Q

KNEE JERK

A

L2,L3,L4

115
Q

UPPER ABDOMINAL REFLEX

A

T8-T10

116
Q

LOWER ABDOMINAL REFLEX

A

T10-T12

117
Q

GENERALIZED MUSCLE WEAKNESS

A

ASTHENIA

118
Q

FLEXOR WITHDRAWAL ONSET AND INTEGRATION

A

28 WKS OF GESTATION; 1-2 MOS

119
Q

CROSSED EXTENSION ONSET AND INTEGRATION

A

28 WKS OF GESTATION; 1-2 MOS

120
Q

TRACTION ONSET AND INTEGRATION

A

28 WKS OF GESTATION; 2-5 MOS

121
Q

MORO ONSET AND INTEGRATION

A

28 WKS OF GESTATION; 5-6 MOS

122
Q

STARTLE ONSET AND INTEGRATION

A

AT BIRTH; PERSISTAS

123
Q

GRASP ONSET AND INTEGRATION

A

PALMAR: BIRTH/PLANTAR: 28 WKS OF GESTATION
PALMAR: 4-6 MOS/PLANTAR: 9 MOS.

124
Q

ATNR ONSET AND INTEGRATION

A

BIRTH ; 4-6 MOS

125
Q

STNR ONSET AND INTEGRATION

A

4-6 MOS ; 8- 12 MOS

126
Q

STLR ONSET AND INTEGRATION

A

BIRTH; 6 MOS

127
Q

ASSOCIATED REACTION ONSET AND INTEGRATION

A

BIRTH - 3 MOS

8-9 YRS

128
Q

POSSITIVE SUPPORTING ONSET AND INTEGRATION

A

BIRTH; 6 MOS

129
Q

SPINAL/PRIMITIVE REFLEXES

A

MORO, STARTLE, GRASP, TRACTION, FLEXOR WITHDRAWAL, CROSSED EXTENSION

130
Q

TONIC/BRAINSTEM REFLEXES

A

ATNR, STNR, STLR, ASSOCIATED RXNS AND POSITIVE SUPPORTING

131
Q

INTRINSIC PATHOLOGY OR D/O

A

DISEASE

132
Q

ANY LOSS OR ABNORMALITY OF PSYCHOLOGICAL, PHYSIOLOGICAL OR ANATOMICAL STRUCTURE OR FUNCTION

A

IMPAIRMENT

133
Q

ANY RESTRICTION OR LACK OF ABILITY TO PERFORM AN ACTIVITY IN THE RANGE OF A NORMAL HUMAN

A

DISABILITY

134
Q

DISADVANTAGE FOR A GIVEN INDIVIDUAL RESULTING FROM AN IMPAIRMENT OR DISABILITY THAT HINDERS THEM TO FULFILL A ROLE THAT IS NORMAL

A

HANDICAP

135
Q

INTERRUPTION OR INTERFERENCE WITH NORMAL PROCESSES AND EFFORTS OF THE ORGANISM TO REGAIN NORMAL STATE

A

ACTIVE PATHOLOGY

136
Q

LIMITATION IN PERFORMANCE AT THE LEVEL OF THE WHOLE ORGANISM/PERSON

A

FUNCTIONAL IMPAIRMENT

137
Q

FEV1 IN MILD COPD

A

> 80 %

138
Q

FEV1 MODERATE COPD

A

50-80%

139
Q

FEV1 SEVERE COPD

A

30-50%

140
Q

FEV1 VERY SEVERE COPD

A

< 30%

141
Q

TRADENAME AND ACTION: ANTICHOLINERGIC

A

ATROVENT - BRONCHODILATION

142
Q

TRADENAME AND ACTION: LONG ACTING BETA 2 AGONIST

A

SEREVENT - BRONCHODILATION

143
Q

SIDE EFFECTS OF ANTICHOLINERGICS

A

THROAT IRRITATION,
DRYING OF TRACHEAL SECRETIONS
TACHYCARDIA
PALPITATIONS

144
Q

SIDE EFFECTS OF SEREVENT

A
TACHYCARDIA
PALPITATIONS
GI DISTRESS
NERVOUSNESS
TREMOR
H/A
DIZZINESS
145
Q

CROMOLYN SODIUM/INTAL: ACTION AND SIDE EFFECT

A

A: PREVENTS INFLAMMATION
S/E: BRONCHOSPASM
THROAT IRRITATION
COUGH

146
Q

STEROIDS/FLOVENT/PREDNISONE: ACTION AND SIDE EFFECT

A
A: ANTI-INFLAMMATORY
S/E: INC BP
SODIUM RETENTION 
MUSCLE WASTING
OSTEOPOROSIS
GI IRRITATION
ATHEROSCLEROSIS
HYPERCHOLESTEROLEMIA
INC SUSCEPTIBILITY TO INFECTION
147
Q

LEUKOTRIENE RECEPTOR ANTAGONIST/SINGULAIR: ACTION AND SIDE EFFECT

A
A: BLOCKS ALLERGIC REACTION
S/E: GI DISTRESS
SORE THROAT
URTI
DIZZINESS
H/A AND NASAL CONESTION
148
Q

METHYLXANTHINE

A

AMINOPHYLLINE

THEOPHYLLINE

149
Q

METHYLXANTHINE: ACTION AND SIDE EFFECT

A
A: BRONCHODILATION
S/E: SEIZURE
CARDIAC ARRHYTHMIAS
GI DISTRESS
TREMOR AND H/A
150
Q

NORMAL/MINOR/MAJOR CARDIAC DYSFUNCTION/PEAK:

CK MB

A

0-3% / 5% / 10% / 14-36 hrs

151
Q

NORMAL/MINOR/MAJOR CARDIAC DYSFUNCTION/PEAK:

LDH

A

127 IU or 100-225 mU/mL / 300-750 mU/ml / >1000 mu/mL

152
Q

NORMAL/MINOR/MAJOR CARDIAC DYSFUNCTION/PEAK:

TROPONIN

A

0-0.2 microgram/ml / 5 / 10 / 24-36 hrs

153
Q

NORMAL/MINOR/MAJOR CARDIAC DYSFUNCTION/PEAK:

MYOGLOBIN

A

<100 ng/ml / 200ng/ml / > 500 ng/ml

154
Q

HR/BP: BETA BLOCKERS

A

DEC/DEC

155
Q

HR/BP: NITRATES

A

INC/DEC

156
Q

HR/BP: CALCIUM CHANNEL BLOCKERS

A

DEC/DEC

157
Q

HR/BP: DIGITALIS

A

DEC/NE

158
Q

HR/BP: DIURETICS

A

NE/NE or dec

159
Q

HR/BP: VASODILATORS

A

INC/DEC

160
Q

HR/BP: ANTIADRENERGIC AGENTS s selective blockade

A

DEC/DEC

161
Q

HR/BP: NICOTINE

A

INC/INC

162
Q

FXNAL CLASS OF pt.s c HEART DSE: CLASS 1

A

4 - 6 cal/min ; 6.5 METS
without limitation in physical activity
ordinary activity - no sx

163
Q

FXNAL CLASS OF pt.s c HEART DSE: CLASS 2

A

3-4 cal/min ; 4.5 METS
slight limitation in physical activity
ordinary act - (+) sx
no sx at rest

164
Q

FXNAL CLASS OF pt.s c HEART DSE: CLASS 3

A

2-3 cal/min; 3 METS
marked limitation in physical activity
less than normal activity - (+) sx
no sx at rest

165
Q

FXNAL CLASS OF pt.s c HEART DSE: CLASS 4

A

1-2 cal/min ; 1.5 MET
(+) sx with any activity and even at rest
inability to carryout any act without discomfort

166
Q

NORMAL/LV/RV/BV: CVP

A

0-8 mmHg / 6 mmHg / 12 mmHg / 12 mmHg

167
Q

NORMAL/LV/RV/BV: PAP

A

9-19 mmHg / 22 mmHg / 16 mmHg / 22 mmHg

168
Q

NORMAL/LV/RV/BV: PCWP

A

6-12 mmHg / 18 mmHg / 10 mmHg / 18 mmHg

169
Q

ASSOCIATED WITH RV FAILURE

A

INCREASED CVP

170
Q

ASSOCIATED WITH LV FAILURE

A

INCREASE PAP AND PCWP

171
Q

INPATIENT CARDIAC REHAB: LEVEL 1

A

1-1.5 METs - ESSENTIALLY BED REST
ARMS SUPPORTED
BED EXERCISES/SITTING DANGLED WITH FEET SUPPORTED
INTRODUCE TO CARDIAC REHAB

172
Q

INPATIENT CARDIAC REHAB: LEVEL 2

A
1.5-2 METS - LIMITED ROOM AMBULATION
15-30 mins sitting - 3-4x/day
LEG EXERCISES
ELECTRIC RAZOR
COMMODE PRIVILEDGE
HEALING INTERVAL
EDUCATE ON RISK FACTORS
173
Q

INPATIENT CARDIAC REHAB: LEVEL 3

A
2-2.5 METS - LIMITED HALL AMBULATION
ROOM OR HALL AMBULATION ~ 5' - 3-4x/day
OPTIONAL STANDING LEG EXERCISES
MANUAL SHAVE
BATHROOM PRIVILEDGE
EDUCATE ON SIZE OF INFARCT AND THE IMPACT OF EXERCISE AND BORG'S RPE
174
Q

INPATIENT CARDIAC REHAB: LEVEL 4

A

2.5-3 METs - PROGRESSIVE HALL AMBULATION
HALL AMBULATION 5-7’ - 3-4x/day
STANDING TRUNK EXERCISES
EDUCATE ON PULSE TAKING AND OUTPATIENT CARDIAC REHAB

175
Q

INPATIENT CARDIAC REHAB: LEVEL 5

A
3-4 METS - PROGRESSIVE HALL AMBULATION
HALL AMBULATION ~ 8-10'
ARM EXERCISES OPTIONAL
STANDING SHOWER
WRITTEN HEP
176
Q

INPATIENT CARDIAC REHAB: LEVEL 6

A

4-5 MET - STAIR CLIMBING

FULL FLIGHT OF STAIRS UP AND DOWN ONE STEP AT A TIME

177
Q

NO EVIDENCE OF HEMODYNAMIC COMPROMISE:

in the HR of beta blocked and non beta blocked pts.

A

beta blocked: not >12 bpm

non: not >20 bpm

178
Q

NO EVIDENCE OF HEMODYNAMIC COMPROMISE: SBP

A

no drop: >10 mmHg

no rise: >30 mmHg

179
Q

NO EVIDENCE OF HEMODYNAMIC COMPROMISE: RPE

A

<13/20

180
Q

NON INVASIVE TEST TO EXAME LE FOR ISCHEMIA, FOLLOWING ELEVATION, LOWERING OF THE LIMB SHOULD RETURN THE SKIN OF THE LIMB TO A PINK COLOR, IF DARK RED AND TAKES >30s = (+) arterial insufficiency

A

RUBOR TEST FOR DEPENDENCY

181
Q

FOR BOTH ARTERIAL AND VENOUS CIRCULATION, CHANGES IN LE VOLUME TESTED DURING REST, STANDING AND LIGHT WALKING; DETECTS VENOUS OBSTRUCTION AND ARTERIAL INFLOW

A

AIR PLETHYSMOGRAPHY (APG)

182
Q

FOR ARTERIAL CIRCULATION, SPECIAL PROVE AND A HEATING ELEMENT MEASURE PROFUSION, MEASUREMENT OF OXYGEN AT SKIN LEVEL = what’s happening at cellular level

PREDICTIVE FOR HEALING OF ULCERS AND AMPUTATION WOUNDS

A

TRANSCUTANEOUS OXYGEN (TcPO2)

183
Q

MEASURES BLOOD FLOW IN SKIN using a modified laser doppler probe

PREDICTIVE FOR HEALING OF ULCERS AND AMPUTATION WOUNDS

A

SKIN PERFUSION PRESSURE (SPP) measurement

184
Q

TIME IT TAKES FOR THE VEINS ON TOP OF FOOT TO REFILL IS RECORDED

A

VENOUS FILLING TIME

185
Q

VENOUS FILLING TIME:
(N) VALUE
ARTERIAL INSUFFICIENCY
VENOUS INSUFFICIENCY

A

15s
>15s
<15s

186
Q

LE IN DEPENDENT POSITION, PALPATE GREAT SAPHENOUS VEIN DISTAL TO KNEE with ONE HAND, other hand proximal to knee 6”(15.2cm), percuss,

positive if wave of fluid is felt at distal site = poss VALVULAR INCOMPETENCY

A

PERCUSSION TEST

187
Q

MEASURES TIME REQUIRED TO REFILL THE VEINS IN THE DORSUM OF THE FOOT; elevate foot, place tourniquet at thigh to prevent backflow

A

trendelenburg test

188
Q

TRENDELENBURG TEST: if within 5s veins distend before tourniquet is released?

A

VALVULAR INCOMPETENCE OF DEEP VEINS

189
Q

TRENDELENBURG TEST: if within 5s veins distend after tourniquet is released?

A

VALVULAR INCOMPETENCE OF SUPERFICIAL VEINS

190
Q

PURPLE OR MAROON LOCALIZED AREA OF DISCOLORED INTACT SKIN OR BLOOD FILLED BLISTER

A

SUSPECTED DEEP TISSUE INJURY

191
Q

TISSUE IS PAINFUL , FIRM, MUSHY , BOGGY, WARMER OR COOLER COMPARED TO ADJACENT TISSUE

A

SUSPECTED DEEP TISSUE INJURY

192
Q

INTACT SKIN WITH NONBLANCHABLE REDNESS

A

STAGE 1

193
Q

AREA MAY BE PAINFUL, FIRM, SOFTER, WARMER, OR COOLER COMPARED TO ADJACENT TISSUE

A

STAGE 1

194
Q

PARTIAL THICKNESS SKIN LOSS OF DERMIS

A

STAGE 2

195
Q

SHALLOW OPEN ULCER WITH A RED PINK WOUND BED

A

STAGE 2

196
Q

FULL THICKNESS TISSUE LOSS , SUB Q VISIBLE

A

STAGE 3

197
Q

UNDERMINING / TUNNELING

A

STAGE 4

198
Q

FULL THICKNESS WITH EXPOSED BONE , TENDON, MUSCLE

A

STAGE 4

199
Q

FULL THICKNESS LOSS, BASE FILLED WITH SLOUGH(YELLOW, TAN, GRAY, GREEN/BROWN) AND ESCHAR

A

UNSTAGEABLE

200
Q

DRAINAGE: CLEAR

A

TRANSUDATED

201
Q

DRAINAGE: CLEAR OR TINGE OF RED/BROWN

A

SEROSANGUINEOUS

202
Q

DRAINAGE: CREAMY, YELLOWISH

A

EXUDATE

203
Q

DRAINAGE: YELLOW, BROWN

A

PUS

204
Q

DRAINAGE: HUES OF YELLOW, BLUE, GREEN

A

INFECTED PUS

205
Q

AFFECTED PRIMARY MOTOR AREA AND MEDIAL ASPECT OF CORTEX AND INTERNAL CAPSULE

A

C/L HEMIPARESIS LE>UE - ACA

206
Q

AFFECTED PRIMARY SENSORY AREA AND MEDIAL ASPECT OF CORTEX

A

C/L HEMISENSORY LOSS LE>UE - ACA

207
Q

AFFECTED CORPUS CALLOSUM

A

PROBLEMS WITH IMITATION AND BIMANUAL TASKS, APRAXIA

208
Q

AFFECTED PM ASPECT OF SUPERIOR FRONTAL GYRUS

A

URINARY INCONTINENCE

209
Q

VBA OCCLUSION: I/L PARALYSIS WITH ATROPHY OF HALF THE TONGUE WITH DEVIATION TO PARALYZED SIDE WHEN TONGUE IS PROTRUDED

A

MEDIAL MEDULLARY SYNDROME

210
Q

VBA OCCLUSION: TETRAPLEGIA

A

COMPLETE BASILARY ARTERY OR LOCKED IN

211
Q

VBA OCCLUSION: DYSPHAGIA AND DYSPHONIA

A

HORNER’S SYNDROME

212
Q

VBA OCCLUSION: I/L PARALYSIS OF CONJUGATE GAZE TO SIDE OF LESION

A

MEDIAL AND LATERAL INFERIOR PONTINE SYNDROME

213
Q

VBA OCCLUSION: I/L NYSTAGMUS

A

WALLENBURG AND MEDIAL INFERIOR PONTINE SYNDROME

214
Q

VBA OCCLUSION: DEAFNESS AND TINNITUS

A

LATERAL INFERIOR PONTINE SYNDROME

215
Q

VBA OCCLUSION: I/L DIPLOPIA AT LATERAL GAZE

A

MEDIAL INFERIOR PONTINE

216
Q

VBA OCCLUSION: (B) CRANIAL NN PALSY

A

COMPLETE BASILAR ARTERY

217
Q

VBA OCCLUSION: COMA

A

COMPLETE BASILAR ARTERY

218
Q

VBA OCCLUSION: HORIZONTAL AND VERTICAL NYSTAGMUS, NAUSEA, VOMITING AND VERTIGO

A

LATERAL INFERIOR PONTINE

219
Q

VBA OCCLUSION: IMPAIRED TACTILE AND PROPRIOCEPTIVE SENSE

A

MEDIAL MEDULLARY AND MEDIAL INFERIOR PONTINE

220
Q

VBA OCCLUSION: LIMB AND GAIT ATAXIA

A

LATERAL MEDULLARY AND MEDIAL INFERIOR PONTINE

221
Q

VBA OCCLUSION: C/L IMPAIRED PAIN AND THERMAL SENSE OVER 50% OF BODY

A

HORNERS AND LATERAL INFERIOR PONTINE SYNDROME

222
Q

VBA OCCLUSION: DEVIATION OF EYES

A

MEDIAL MIDPONTINE SYNDROME

223
Q

VBA OCCLUSION: ATAXIA OF LIMBS

A

MEDIAL AND LATERAL MIDPONTINE SYNDROME

224
Q

VBA OCCLUSION: PARALYSIS OF MM OF MASTICATION

A

LATERAL MIDPONTINE SYNDROME

225
Q

VBA OCCLUSION: INTERNUCLEAR OPTHALMOPLEGIA

A

MEDIAL SUPERIOR PONTINE SYNDROME

226
Q

VBA OCCLUSION: LOSS OF OPTOKINETIC NYSTAGMUS

A

LATERAL SUPERIOR PONTINE SYNDROME

227
Q

VBA OCCLUSION: LOSS OF TOUCH VIBRATION AND POSITION SENSE MORE IN LE THAN UE

A

LATERAL SUPERIOR PONTINE SYNDROME